Feedback regulation of lymphocyte signalling

Nature Reviews Immunology

Volumn 4, Issue 4, 2004, Pages 269-277

  Reth, Michael ^a   Brummer, Tilman ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN;

CELL ACTIVITY; CELL FUNCTION; CELL SURFACE; CELL SURVIVAL; FEEDBACK SYSTEM; HUMAN; LIGAND BINDING; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; RECEPTOR BINDING; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

EID: 1842681652     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri1335     Document Type: Review

References (111)

1. Kurosaki, T. Genetic analysis of B cell antigen receptor signaling. Annu. Rev. Immunol. 17, 555-592 (1999).
2. Mak, T. W., Penninger, J. M. & Ohashi, P. S. Knockout mice: a paradigm shift in modern immunology. Nature Rev. Immunol. 1, 11-19 (2001).
3. Marshall, C. J. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80, 179-185 (1995).
4. Adachi, S. & Iwata, M. Duration of calcineurin and Erk signals regulates CD4/CD8 lineage commitment of thymocytes. Cell. Immunol. 215, 45-53 (2002).
5. Sharp, L. L., Schwarz, D. A., Bott, C. M., Marshall, C. J. & Hedrick, S. M. The influence of the MAPK pathway on T cell lineage commitment. Immunity 7, 609-618 (1997).
6. Sugawara, T., Moriguchi, T., Nishida, E. & Takahama, Y. Differential roles of ERK and p38 MAP kinase pathways in positive and negative selection of T lymphocytes. Immunity 9, 565-574 (1998).
7. Xu, R., Seger, R. & Pecht, I. Cutting edge: extracellular signal-regulated kinase activates Syk: a new potential feedback regulation of Fcε receptor signaling. J. Immunol. 163, 1110-1114 (1999).
8. Brummer, T., Naegele, H., Reth, M. & Misawa, Y. Identification of novel ERK-mediated feedback phosphorylation sites at the C-terminus of B-Raf. Oncogene 22, 8823-8834 (2003).
9. Rolli, V. et al. Amplification of B cell antigen receptor signaling by a Syk/ITAM positive feedback loop. Mol. Cell 10, 1057-1069 (2002). By reconstructing B-cell receptor (BCR)-signalling pathways in Drosophila S2 cells, the authors provide insights into the mechanisms of immunoreceptor tyrosine-based activation motif (ITAM) phosphorylation and identify a positive-feedback loop involved in SYK activation.
10. 2 synthesis: importance for calcium signaling and PI3K activity. Immunity 19, 669-678 (2003). The authors Identify Bruton's tyrosine kinase (BTK) as a stimulator of a positive-feedback loop that not only ensures substrate supply for the BTK activator phosphatidylinositol 3-kinase (PI3K), but also helps to sustain the activity of BTK effectors such as phospholipase C-γ (PLC-γ).
11. Lynch, D. K. & Daly, R. J. PKB-mediated negative feedback tightly regulates mitogenic signalling via Gab2. EMBO J. 21, 72-82 (2002).
12. Lax, I. et al. The docking protein FRSα controls a MAP kinase-mediated negative feedback mechanism for signaling by FGF receptors. Mol. Cell 10, 709-719 (2002).
13. Reth, M. & Wienands, J. Initiation and processing of signals from the B cell antigen receptor. Annu. Rev. Immunol. 15, 453-479 (1997).
14. Ferrell, J. E., Jr. Self-perpetuating states in signal transduction: positive feedback, double-negative feedback and bistability. Curr. Opin. Cell Biol. 14, 140-148 (2002).
15. Pawson, T. & Scott, J. D. Signaling through scaffold, anchoring, and adaptor proteins. Science 278, 2075-2080 (1997).
16. Jordan, M. S., Singer, A. L. & Koretzky G. A. Adaptors as central mediators of signal transduction in immune cells. Nature Immunol. 4, 110-116 (2003).
17. Schlessinger, J. Signal transduction. Autoinhibition control. Science 300, 750-752 (2003).
18. Harrison, S. C. Variation on an Src-like theme. Cell 112, 737-740 (2003).
19. Hof, P., Pluskey, S., Dhe-Paganon, S., Eck, M. J. & Shoelson, S. E. Crystal structure of the tyrosine phosphatase SHP-2. Cell 92, 441-450 (1998).
20. Stofega, M. R., Argetsinger, L. S., Wang, H., Ullrich, A. & Carter-Su, C. Negative regulation of growth hormone receptor/JAK2 signaling by signal regulatory protein α. J. Biol. Chem. 275, 28222-28229 (2000).
21. Neel, B. G., Gu, H. & Pao, L. The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling. Trends Biochem. Sci. 28, 284-293 (2003).
22. Blasioli, J., Paust, S. & Thomas, M. L. Definition of the sites of interaction between the protein tyrosine phosphatase SHP-1 and CD22. J. Biol. Chem. 274, 2303-2307 (1999).
23. Meng, T. C., Fukada, T. & Tonks, N. K. Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. Mol. Cell 9, 387-399 (2002).
24. 2+ mobilization through distinct pathways. EMBO J. 13, 1341-1349 (1994).
25. Cornall, R. J., Cheng, A. M., Pawson, T. & Goodnow, C. C. Role of Syk in B-cell development and antigen-receptor signaling. Proc. Natl Acad. Sci. USA 97, 1713-1718 (2000).
26. Kurosaki, T. et al. Role of the Syk autophosphorylation site and SH2 domains in B cell antigen receptor signaling. J. Exp. Med. 182, 1815-1823 (1995).
27. Keshvara, L. M., Isaacson, C., Harrison, M. L. & Geahlen, R. L. Syk activation and dissociation from the B-cell antigen receptor is mediated by phosphorylation of tyrosine 130. J. Biol. Chem. 272, 10377-10381 (1997).
28. Furlong, M. T. et al. Identification of the major sites of autophosphorylation of the murine protein-tyrosine kinase Syk. Biochim. Biophys. Acta 1355, 177-190 (1997).
29. Hong, J. J., Yankee, T. M., Harrison, M. L. & Geahlen, R. L. Regulation of signaling in B cells through the phosphorylation of Syk on linker region tyrosines. A mechanism for negative signaling by the Lyn tyrosine kinase. J. Biol. Chem. 277, 31703-31714 (2002).
30. Yankee, T. M., Keshvara, L. M., Sawasdikosol, S., Harrison, M. L. & Geahlen, R. L. Inhibition of signaling through the B cell antigen receptor by the protooncogene product, c-Cbl, requires Syk tyrosine 317 and the c-Cbl phosphotyrosine-binding domain. J. Immunol. 163, 5827-5835 (1999).
31. Flaswinkel, H. & Reth, M. Dual role of the tyrosine activation motif of the Ig-α protein during signal transduction via the B cell antigen receptor. EMBO J. 13, 83-89 (1994).
32. Saijo, K. et al. Essential role of Src-family protein tyrosine kinases in NF-κB activation during B cell development. Nature Immunol. 4, 274-279 (2003).
33. Kraus, M. et al. Interference with immunoglobulin (Ig)α immunoreceptor tyrosine-based activation motif (ITAM) phosphorylation modulates or blocks B cell development, depending on the availability of an Igβ cytoplasmic tail. J. Exp. Med. 194, 455-469 (2001).
34. Campbell, S. L., Khosravi-Far, R., Rossman, K. L., Clark, G. J. & Der, C. J. Increasing complexity of Ras signaling. Oncogene 17, 1395-1413 (1998).
35. Hancock, J. F. Ras proteins: different signals from different locations. Nature Rev. Mol. Cell Biol. 4, 373-384 (2003).
36. Hamad, N. M. et al. Distinct requirements for Ras oncogenesis in human versus mouse cells. Genes Dev. 16, 2045-2057 (2002).
37. Shaw, A. C., Swat. W., Ferrini, R., Davidson, L. & Alt, F. W. Activated Ras signals developmental progression of recombinase-activating gene (RAG)-deficient pro-B lymphocytes. J. Exp. Med. 189, 123-129 (1999).
38. Gold, M. R. To make antibodies or not: signaling by the B-cell antigen receptor. Trends Pharmacol. Sci. 23, 316-324 (2002).
39. Alberola-Ila, J. & Hernandez-Hoyos, G. The Ras/MAPK cascade and the control of positive selection. Immunol. Rev. 191, 79-96 (2003).
40. Dower, N. A. et al. RasGRP is essential for mouse thymocyte differentiation and TCR signaling. Nature Immunol. 1, 317-321 (2000).
41. Priatel, J. J., Teh, S. J., Dower, N. A., Stone, J. C. & Teh, H. S. RasGRP1 transduces low-grade TCR signals which are critical for T cell development, homeostasis, and differentiation. Immunity 17, 617-627 (2002).
42. Oh-Hora, M., Johmura, S., Hashimoto, A., Hikida, M. & Kurosaki, T. Requirement for Ras guanine nucleotide releasing protein 3 in coupling phospholipase C-γ2 to Ras in B cell receptor signaling. J. Exp. Med. 198, 1841-1851 (2003).
43. Margarit, S. M. et al. Structural evidence for feedback activation by Ras. GTP of the Ras-specific nucleotide exchange factor SOS. Cell 112, 685-695 (2003). Crystallographic analyses showing a ternary son-of-sevenless (SOS)-RAS complex with one RAS molecule bound to the catalytic module of SOS and one RAS-GTP molecule bound to a regulatory site distal to the active site of SOS. This indicates that RAS-GTP stabilizes the active site of SOS allosterically and mediates a positive-feedback mechanism for the spatial and temporal regulation of RAS.
44. Fruman, D. A., Satterthwaite, A. B. & Witte, O. N. Xid-like phenotypes: a B cell signalosome takes shape. Immunity 13, 1-3 (2000).
45. Schwartzberg, P. L. Amplifying Btk's signal. Immunity 19, 634-636 (2003).
46. Healy, J. I. & Goodnow, C. C. Positive versus negative signaling by lymphocyte antigen receptors. Annu. Rev. Immunol. 16, 645-670 (1998).
47. Galm, O., Yoshikawa, H., Esteller, M., Osieka, R. & Herman, J. G. SOCS-1, a negative regulator of cytokine signaling, is frequently silenced by methylation in multiple myeloma. Blood 101, 2784-2788 (2003).
48. Hibbs, M. L. et al. Sustained activation of Lyn tyrosine kinase in vivo leads to autoimmunity. J. Exp. Med. 196, 1593-1604 (2002).
49. Cornall, R. J. et al. Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection. Immunity 8, 497-508 (1998).
50. O'Keefe, T. L., Williams, G. T., Davies, S. L. & Neuberger, M. S. Hyperresponsive B cells in CD22-deficient mice. Science 274, 798-801 (1996).
51. Nitschke, L., Carsetti, R., Ocker, B., Kohler, G. & Lamers, M. C. CD22 is a negative regulator of B-cell receptor signalling. Curr. Biol. 7, 133-143 (1997). References 48 to 51 provide detailed genetic and biochemical analyses of the LYN-CD22-SHP1 negative-feedback loop in B cells.
52. Kang, S. W. et al. PKCP modulates antigen receptor signaling via regulation of Btk membrane localization. EMBO J. 20, 5692-5702 (2001). This work provides a molecular mechanism by which protein kinase C-β (PKC-β) downregulates BCR-induced BTK activity through serine phosphorylation of BTK as part of a negative-feedback loop.
53. Cochet, C., Gill, G. N., Meisenhelder, J., Cooper, J. A. & Hunter, T. C-kinase phosphorylates the epidermal growth factor receptor and reduces its epidermal growth factor-stimulated tyrosine protein kinase activity. J. Biol. Chem. 259, 2553-2558 (1984).
54. Muller, R., Wienands, J. & Reth, M. The serine and threonine residues in the Ig-α cytoplasmic tail negatively regulate immunoreceptor tyrosine-based activation motif-mediated signal transduction. Proc. Natl Acad. Sci. USA 97, 8451-8454 (2000).
55. Losch, F. O. et al. Activation of T cells via tumor antigen specific chimeric receptors: the role of the intracellular signaling domain. Int. J. Cancer 103, 399-407 (2003).
56. Allouche, M. Basic fibroblast growth factor and hematopoiesis. Leukemia 9, 937-42 (1995).
57. de Haan, G. et al. In vitro generation of long-term repopulating hematopoietic stem cells by fibroblast growth factor-1. Dev Cell 4, 241-251 (2003).
58. Kronfeld, I., Kazimirsky, G., Gelfand, E. W. & Brodie, C. NGF rescues human B lymphocytes from anti-IgM induced apoptosis by activation of PKCζ. Eur. J. Immunol. 32, 136-143 (2002).
59. Gu, H. & Neel, B. G. The 'Gab' in signal transduction. Trends Cell Biol. 13, 122-130 (2003).
60. Herrera, R. & Sebolt-Leopold, J. S. Unraveling the complexities of the Raf/MAP kinase pathway for pharmacological intervention. Trends Mol. Med. 8, S27-S31 (2002).
61. Iritani, B. M., Alberola-Ila, J., Forbush, K. A. & Penmutter, R. M. Distinct signals mediate maturation and allelic exclusion in lymphocyte progenitors. Immunity 10, 713-722 (1999).
62. Rui, L., Vinuesa, C. G., Blasioli, J. & Goodnow, C. C. Resistance to CpG DNA-induced autoimmunity through tolerogenic B cell antigen receptor ERK signaling. Nature Immunol. 4, 594-600 (2003).
63. Fleming, H. E. & Paige, C. J. Pre-B cell receptor signaling mediates selective response to IL-7 at the pro-B to pre-B cell transition via an ERK/MAP kinase-dependent pathway. Immunity 15, 521-531 (2001).
64. Flemming, A., Brummer, T., Reth, M. & Jumaa, H. The adaptor protein SLP-65 acts as a tumor suppressor that limits pre-B cell expansion. Nature Immunol. 4, 38-43 (2003).
65. Gardner, A. M., Vaillancourt, R. R., Lange-Carter, C. A. & Johnson, G. L. MEK-1 phosphorylation by MEK kinase, Raf, and mitogen-activated protein kinase: analysis of phosphopeptides and regulation of activity. Mol. Biol. Cell 5, 193-201 (1994).
66. Mansour, S. J. et al. Mitogen-activated protein (MAP) kinase phosphorylation of MAP kinase kinase: determination of phosphorylation sites by mass spectrometry and site-directed mutagenesis. J. Biochem. (Tokyo) 116, 304-314 (1994).
67. Clemens, J. C. et al. Use of double-stranded RNA interference in Drosophila cell lines to dissect signal transduction pathways. Proc. Natl Acad. Sci. USA 97, 6499-6503 (2000).
68. Roy, F., Laberge, G., Douziech, M., Ferland-McCollough, D. & Therrien, M. KSR is a scaffold required for activation of the ERK/MAPK module. Genes Dev. 16, 427-438 (2002).
69. Alessi, D. R., Cuenda, A., Cohen, P., Dudley, D. T. & Saltiel, A. R. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270, 27489-27494 (1995).
70. Wartmann, M., Hofer, P., Turowski, P., Saltiel, A. R. & Hynes, N. E. Negative modulation of membrane localization of the Raf-1 protein kinase by hyperphosphorylation. J. Biol. Chem. 272, 3915-3923 (1997).
71. Brummer, T., Shaw, P. E., Reth, M. & Misawa, Y. Inducible gene deletion reveals different roles for B-Raf and Raf-1 in B-cell antigen receptor signalling. EMBO J. 21, 5611-5622 (2002).
72. Ueki, K. et al. Feedback regulation of mitogen-activated protein kinase kinase kinase activity of c-Raf-1 by insulin and phorbol ester stimulation. J. Biol. Chem. 269, 15756-15761 (1994).
73. Waters, S. B. et al. Desensitization of Ras activation by a feedback disassociation of the SOS-Grb2 complex. J. Biol. Chem. 270, 20883-20886 (1995).
74. Corbalan-Garcia, S., Yang, S. S., Degenhardt, K. R. & Bar-Sagi, D. Identification of the mitogen-activated protein kinase phosphorylation sites on human Sos1 that regulate interaction with Grb2. Mol. Cell. Biol. 16, 5674-5682 (1996).
75. Douville, E. & Downward, J. EGF induced SOS phosphorylation in PC12 cells involves P90 RSK-2. Oncogene 15, 373-383 (1997).
76. Harmer, S. L. & DeFranco, A. L. Shc contains two Grb2 binding sites needed for efficient formation of complexes with SOS in B lymphocytes. Mol. Cell. Biol. 17, 4087-4095 (1997).
77. D'Angelo, G. et al. 16K human prolactin inhibits vascular endothelial growth factor-induced activation of Ras in capillary endothelial cells. Mol. Endocrinol. 13, 692-704 (1999).
78. Waters, S. B., Yamauchi, K. & Pessin, J. E. Insulin-stimulated disassociation of the SOS-Grb2 complex. Mol. Cell. Biol. 15, 2791-2799 (1995).
79. Buday, L., Warne, P. H. & Downward, J. Downregulation of the Ras activation pathway by MAP kinase phosphorylation of Sos. Oncogene 11, 1327-1331 (1995).
80. Zhang, W., Sloan-Lancaster, J., Kitchen, J., Trible, R. P. & Samelson, L. E. LAT: the ZAP-70 tyrosine kinase substrate that links T cell receptor to cellular activation. Cell 92, 83-92 (1998).
81. Langlois, W. J., Sasaoka, T., Saltiel, A. R. & Olefsky, J. M. Negative feedback regulation and desensitization of insulin- and epidermal growth factor-stimulated p21ras activation. J. Biol. Chem. 270, 25320-25323 (1995).
82. Alexander, W. S. Suppressors of cytokine signalling (SOCS) in the immune system. Nature Rev. Immunol. 2, 410-416 (2002).
83. Hoffmann, A., Levchenko, A., Scott, M. L. & Baltimore, D. The IκB-NF-κB signaling module: temporal control and selective gene activation. Science 298, 1241-1245 (2002).
84. Ravetch, J. V. & Lanier, L. L. Immune inhibitory receptors. Science 290, 84-89 (2000).
85. Reth, M. Hydrogen peroxide as second messenger in lymphocyte activation. Nature Immunol. 3, 1129-1134 (2002).
86. Watts, J. D., Sanghera, J. S., Pelech, S. L. & Aebersold, R. Phosphorylation of serine 59 of p56lck in activated T cells. J. Biol. Chem. 268, 23275-23282 (1993).
87. Joung, I. et al. Modification of Ser59 in the unique N-terminal region of tyrosine kinase p56lck regulates specificity of its Src homology 2 domain. Proc. Natl Acad. Sci. USA 92, 5778-5782 (1995).
88. Winkler, D. G. et al. Phosphorylation of Ser-42 and Ser-59 in the N-terminal region of the tyrosine kinase p56lck. Proc. Natl Acad. Sci. USA 90, 5176-5180 (1993).
89. Stefanova, I. et al. TCR ligand discrimination is enforced by competing ERK positive and SHP-1 negative feedback pathways. Nature Immunol. 4, 248-254 (2003). This paper describes how T-cell receptor (TCR)-induced LCK activity is balanced by positive- and negative-feedback loops and provides a physiological relevance for the extracellular signal-regulated kinase (ERK)-mediated feedback phosphorylation of LCK that was discovered a decade earlier.
90. Schebesta, M., Heavey, B. & Busslinger, M. Transcriptional control of B-cell development. Curr. Opin. Immunol. 14, 216-223 (2002).
91. Shaffer, A. L. et al. Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program. Immunity 17, 51-62 (2002).
92. Lin, K. I., Tunyaplin, C. & Calame, K. Transcriptional regulatory cascades controlling plasma cell differentiation. Immunol. Rev. 194, 19-28 (2003).
93. Moriyama, M., Yamochi, T., Semba, K., Akiyama, T. & Mori, S. BCL-6 is phosphorylated at multiple sites in its serine- and proline-clustered region by mitogen-activated protein kinase (MAPK) in vivo. Oncogene 14, 2465-2474 (1997).
94. Niu, H., Ye, B. H. & Dalla-Favera, R. Antigen receptor signaling induces MAP kinase-mediated phosphorylation and degradation of the BCL-6 transcription factor. Genes Dev. 12, 1953-1961 (1998).
95. Calame, K. L. Plasma cells: finding new light at the end of B cell development. Nature Immunol. 2, 1103-1108 (2001).
96. Rao, N., Dodge, I. & Band, H. The Cbl family of ubiquitin ligases: critical negative regulators of tyrosine kinase signaling in the immune system. J. Leukoc. Biol. 71, 753-763 (2002).
97. Jang, I. K. & Gu, H. Negative regulation of TCR signaling and T-cell activation by selective protein degradation. Curr. Opin. Immunol. 15, 315-320 (2003).
98. Thien, C. B. & Langdon, W. Y. Cbl: many adaptations to regulate protein tyrosine kinases. Nature Rev. Mol. Cell Biol. 2, 294-307 (2001).
99. Watts, J. D. et al. Identification by electrospray ionization mass spectrometry of the sites of tyrosine phosphorylation induced in activated Jurkat T cells on the protein tyrosine kinase ZAP-70. J. Biol. Chem. 269, 29520-29529 (1994).
100. Murphy, M. A. et al. Tissue hyperplasia and enhanced T-cell signalling via ZAP-70 in c-Cbl-deficient mice. Mol. Cell Biol. 18, 4872-4882 (1998).
101. Naramura, M., Kole, H. K., Hu, R. J. & Gu, H. Altered thymic positive selection and intracellular signals in Cbl-deficient mice. Proc. Natl Acad. Sci. USA 95, 15547-15552 (1998).
102. Tognon, C. E. et al. Regulation of RasGRP via a phorbol ester-responsive C1 domain. Mol. Cell. Biol. 18, 6995-7008 (1998).
103. Su, Y. W. & Jumaa, H. LAT links the pre-BCR to calcium signaling. Immunity 19, 295-305 (2003).
104. Niiro, H., Maeda, A., Kurosaki, T. & Clark, E. A. The B lymphocyte adaptor molecule of 32 kD (Bam32) regulates B cell antigen receptor signaling and cell survival. J. Exp. Med. 195, 143-149 (2002).
105. Han, A., Saijo, K., Mecklenbrauker, I., Tarakhovsky, A. & Nussenzweig, M. C. Bam32 links the B cell receptor to ERK and JNK and mediates B cell proliferation but not survival. Immunity 19, 621-632 (2003).
106. Reynolds, L. F. et al. Vav1 transduces T cell receptor signals to the activation of the Ras/ERK pathway via LAT, Sos and RasGRP1. J. Biol. Chem. (in the press)
107. Adachi, T. et al. SHP-1 requires inhibitory co-receptors to down-modulate B cell antigen receptor-mediated phosphoryiation of cellular substrates. J. Biol. Chem. 276, 26648-26655 (2001).
108. Mizuno, K. et al. Src homology region 2 (SH2) domain-containing phosphatase-1 dephosphorylates B cell linker protein/SH2 domain leukocyte protein of 65 kDa and selectively regulates c-Jun NH2-terminal kinase activation in B cells. J. Immunol. 165, 1344-1351 (2000).
109. Pani, G., Kozlowski, M., Cambier, J. C., Mills, G. B. & Siminovitch, K. A. Identification of the tyrosine phosphatase PTP1C as a B cell antigen receptor-associated protein involved in the regulation of B cell signaling. J. Exp. Med. 181, 2077-2084 (1995).
110. Cyster, J. G. & Goodnow, C. C. Protein tyrosine phosphatase 1C negatively regulates antigen receptor signaling in B lymphocytes and determines thresholds for negative selection. Immunity 2, 13-24 (1995).
111. Doody, G. M. et al. A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP. Science 269, 242-244 (1995).